CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.

[1]  B. Griffith,et al.  Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. , 1985, Human immunology.

[2]  C. Corrigan,et al.  T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMA , 1988, The Lancet.

[3]  R. Crystal,et al.  T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. , 1988, Clinical immunology and immunopathology.

[4]  M. López-Botet,et al.  Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. , 1993, Chest.

[5]  R. Pabst,et al.  Lymphocytes migrate from the bronchoalveolar space to regional bronchial lymph nodes. , 1995, American journal of respiratory and critical care medicine.

[6]  D. Littman,et al.  Expression cloning of new receptors used by simian and human immunodeficiency viruses , 1997, Nature.

[7]  E. Butcher,et al.  Lymphocyte trafficking and regional immunity. , 1999, Advances in immunology.

[8]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[9]  Stuart B. Goodman,et al.  Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.

[10]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[11]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[12]  James J. Campbell,et al.  CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin , 2001, The Journal of experimental medicine.

[13]  James J. Campbell,et al.  Expression of Chemokine Receptors by Lung T Cells from Normal and Asthmatic Subjects1 , 2001, The Journal of Immunology.

[14]  N. Miyasaka,et al.  Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[15]  B. Beghé,et al.  Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.

[16]  N. Kadowaki,et al.  Distribution and kinetics of SR‐PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells , 2005, Journal of leukocyte biology.

[17]  D. Adams,et al.  CXC Chemokine Ligand 16 Promotes Integrin-Mediated Adhesion of Liver-Infiltrating Lymphocytes to Cholangiocytes and Hepatocytes within the Inflamed Human Liver1 , 2005, The Journal of Immunology.

[18]  I. Pavord,et al.  Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  L. Lanier,et al.  Evidence for NK Cell Subsets Based on Chemokine Receptor Expression1 , 2006, The Journal of Immunology.

[20]  A. Hamsten,et al.  Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease. , 2006, Atherosclerosis.

[21]  M. Mack,et al.  Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. , 2006, Blood.

[22]  T. Issekutz,et al.  CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen‐induced Th2 lung inflammation but is only a weak mediator of chemotaxis , 2007, Immunology.

[23]  C. Weber,et al.  Transmembrane chemokines: Versatile ‘special agents’ in vascular inflammation , 2007, Thrombosis and Haemostasis.